DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network. Thromb Res 2023 Sep;229:146-148
Date
07/16/2023Pubmed ID
37454464DOI
10.1016/j.thromres.2023.07.004Scopus ID
2-s2.0-85165295419 (requires institutional sign-in at Scopus site)Author List
Martin KA, Lancki N, Kreuziger LB, Li C, Eyster ME, Sanfilippo K, Woller SC, Rosovsky RPAuthor
Lisa M. Baumann Kreuziger MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, OralAnticoagulants
Factor Xa Inhibitors
Humans
Retrospective Studies
Rivaroxaban
Venous Thromboembolism
Warfarin
